55KRC: Death of Kirstie Alley highlights importance of colon cancer screening
Actor Kirstie Alley died of colon cancer at age 71 last month, with her family stating the cancer had only been recently discovered prior to her death.
Carla F. Justiniano, MD, a University of Cincinnati Cancer Center colorectal surgeon and assistant professor in UC's College of Medicine, joined 55KRC's Simply Medicine radio show and podcast to discuss colon cancer screening following Alley's death. She noted colon cancer often does not have any noticeable symptoms, which leads to late detection after it has reached advanced stages.
Justiniano said the best prevention for colon cancer is to begin regular colonoscopies beginning at age 45. If the results are clear, colonoscopies are recommended every 10 years, with a more frequent schedule possibly needed in certain cases.
"What’s really special about a colonoscopy compared to some of the other screening methods is that we can both see what’s going on and detect cancer, but we can also prevent some cancer," she said. "If we find little polyps or even big polyps, we can simply remove them at the same time of the colonoscopy. So the colonoscopy is not only identifying a cancer or problem, but it can also prevent one by removing the little polyps that might be there already."
Listen to the Simply Medicine interview. (Note: Segment begins around 32:03 mark.)
Featured photo at top courtesy of iStock Photo.
Related Stories
Cincinnati Children's LEND Program opens doors for UC graduate nursing students
June 9, 2026
UC graduate nursing students are broadening their expertise and career opportunities through the Cincinnati Children's LEND Program.
Patients with developmental disabilities may benefit with an integrated care model
June 9, 2026
Researchers from the University of Cincinnati and Ohio State University have found that adults with developmental disabilities who have integrated care were less likely to go to the emergency room or be hospitalized than others who were not. Their work was published in Disability and Health Journal.
UC physician-researcher's work yields landmark five-year data for Crohn's disease drug
June 8, 2026
The University of Cincinnati College of Medicine’s Anita Afzali, MD, leads a landmark study revealing five-year efficacy and safety data for a Crohn’s disease drug called guselkumab.